Özet:

Goal: Both ischemic heart disease and coronavirus disease 2019 (COVID-19) form two main groups of patients who frequently apply to emergency services in recent periods. In cases of acute coronary syndrome (ACS), we aimed at assessing the impact of COVID-19 pandemic on demographic and clinical processes. Method: This retrospective, one-centric study was conducted on ACS patients seeking emergency service between 10 March 2019-11 March 2021. Patients were divided into two periods as pandemic and prepandemic, while the period of pandemic was grouped as COVID (+) and (-) . The ACS classification of patients, clinical and laboratory results were evaluated. Results: The average age of 1,067 patients involved was 58,0±19,2 years and 785 (73,5%) men. Of the 542 incidents in the pre-pandemic period, 262 (48.3%) were non-ST elevation myocardial infarction (NSTEMI) and 202 (37.3%) ST elevation myocardial infarction (STEMI). Of the COVID (+) incidents in the pandemic group, 194 of the 252 patients (76.9 percent) were NSTEMI and 34 (13.6 percent) STEMI (p=0,001, p=0.013). In the pandemic period, 7 of the 8 deaths in the COVID group (-) were caused by STEMI (87.5 percent). In contrast, 26 COVID (+) deaths of 20 (77) were followed in the NSTEMI group. The NSTEMI mortality was significantly higher in the COVID (+) group (p=0,001). Result: The rapid assessment of ACS incidents in emergency service is very effective on the patient’s forecast. The correct assessment of the severity of the COVID-19 disease, risk factors, laboratory findings and results, the comprehension of the mechanisms that can trigger ACS in severe acute respiratory syndrome-coronavirus-2 infection, and the development of strategies that will facilitate the diagnosis and treatment, are of great importance.

Anahtar Kelimeler: